department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

vicadrostat · pharmadog

pharmadog
drugs
vicadrostat

drug · small molecule

patient view →

vicadrostat

Phase 3updated 2mo ago

by Boehringer Ingelheim International GmbH🔗 ChEMBL

Phase 3

community read0 votes

Small molecule drug with a maximum clinical stage of Phase 1.

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

generic

vicadrostat

indication

Diastolic Heart Failure (HFpEF)

phase

phase_3

Data sources

ClinicalTrials.gov · OpenTargets

last refreshed 41m ago

Found something off?

🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying vicadrostat

phase3A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failurerecruitingn=6,000
phase3A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heartrecruitingn=4,200
phase3EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Diseaserecruitingn=11,800
phase1A Study in Healthy People to Test How Vicadrostat Affects the Heartactive not recruitingn=45
phase2A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Diseaseactive not recruitingn=416
phase2Comparative Study on the Mode of Action of Vicadrostat and Spironolactone on Protein Profiles and Renal Hemodynamic Effects (COMPARE-VS)recruitingn=100
phase1A Study in Healthy People to Test How 2 Different Formulations of a Combination Treatment (Vicadrostat and Empagliflozin) Are Taken up in the Body and How Food Influences the Amount of the Medicines in the Bloodcompletedn=32
phase1A Study in Healthy Men to Compare the Amount of Vicadrostat and Empagliflozin in the Blood When Taken Separately and Togethercompletedn=15

more trials →